MHRA Drug Safety Update November 2022
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 4 November 2022) has been published and includes articles on:
- Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
- Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you
- COVID-19 vaccines and medicines: updates for November 2022
- Letters and medicine recalls sent to healthcare professionals in October 2022
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.